Using the EPiC Platform to Accellerate Manufacturing of INV441
Time: 2:00 pm
day: Conference Day One PM
Details:
- Leveraging a closed system to enable rapid, same-day reinfusion of viable TIL products
- Adapting classical TIL expansion protocols with novel cytokine and chemokine mixes to enhance safety
- Implementing flexible source material processing to streamline clinical readiness for glioblastoma patients
